An inhibitory role for Sema4A in antigen-specific allergic asthma

Area of Science:

• Immunology
• Allergy Research
• T-cell Differentiation

Background:

• Class IV semaphorin Sema4A is crucial for Th1 immune responses.
• The role of Sema4A in Th2-mediated allergic diseases remains largely uncharacterized.

Purpose of the Study:

• To investigate the regulatory role of Sema4A in mouse models of allergic diseases, focusing on allergic asthma.
• To clarify the impact of Sema4A on Th2 cell responses in the context of allergic inflammation.

Main Methods:

• Utilized Sema4a (-/-) mice and wild-type (WT) littermates on a BALB/c background.
• Induced experimental asthma via ovalbumin (OVA) sensitization and intranasal challenges.
• Assessed airway hyperreactivity (AHR), airway inflammation, Th2 cytokine production, and direct effects of Sema4A-Fc on CD4(+) T cells.

Main Results:

• Sema4a (-/-) mice exhibited spontaneous atopic dermatitis-like skin lesions and enhanced AHR, lung inflammation, and Th2 responses upon OVA challenge.
• Systemic administration of Sema4A-Fc ameliorated AHR and lung inflammation in WT mice.
• Sema4A-Fc directly inhibited IL-4 production by OVA-specific CD4(+) T cells, independent of the Sema4A receptor Tim-2.

Conclusions:

• Sema4A exerts an inhibitory role in the pathogenesis of Th2-type allergic diseases, including allergic asthma.
• Targeting Sema4A may represent a therapeutic strategy for managing allergic inflammatory conditions.